News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
An expert committee recommended that the drug be offered to a narrow group of patients with early-stage Alzheimer’s disease.
At Kennesaw State University’s X Lab, assistant professor of information technology Chloe Yixin Xie and sophomore computer science student Johaan Kathilankal Jis are leading efforts to fight Alzheimer ...
Eli Lilly & Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group of patients, potentially paving the way for it to become the second drug in ...
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...
MS may increase the risk of Alzheimer's disease, possibly due to changes in the activity of immune T-cells, a new genetic ...
Eli Lilly has cleared a major hurdle in its bid to win European approval for its Alzheimer's disease drug Kisunla.
18h
News Medical on MSNMathematics offers new clues in the fight against Alzheimer's
Mathematics may not be the first thing people associate with Alzheimer's disease research. But for Pedro Maia, an assistant ...
The model reveals that more connected brain regions are more prone to damage, while isolated areas remain resilient. This approach offers a powerful framework for understanding disease progression and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results